Specialities

Cardiology

Hypertension and nephrology

FEBRUARY 28, 2024

[Investigation of lipid abnormalities in adult patients with hypertension using data mining method]

KOVÁCS Beáta, NÉMETH Ákos, DARÓCZY Bálint, KARÁNYI Zsolt, MARODA László, DIÓSZEGI Ágnes, PÁLL Dénes, HARANGI Mariann

[Hypertension and hyperlipidemia frequently coexist, and their interaction amplifies overall atherosclerotic cardiovascular disease risk. We aimed to investigate lipid abnormalities and their associations with body mass index (BMI) in a large adult hypertensive patient population with the help of data mining.]

Hypertension and nephrology

FEBRUARY 28, 2024

[Patients with diabetes, renal failure and perimenopausal hypertension]

ÁBRAHÁM György

[The determinants of cardiovascular (CV) morbidity and mortality is sympathetic overweight, which is the main risk factor for CVD. factors - hypertension (HT), diabetes mellitus (T2DM), renal function deterioration (CKD), dyslipidaemia and, in women, the perimenopausal status - significantly potentiates the adverse effects of diabetes, dyslipidemia, diabetes mellitus.]

Hypertension and nephrology

FEBRUARY 28, 2024

[Important effects of renin-angiotensin system and angiotensin receptor blockers. Focus on valsartan]

FARSANG Csaba

[Blockade of AT1-receptors causes arteriolar vasodilation leading to the decrease the total peripheral resistance (TPR), the aldosterone secretion, and the sodium reabsorption in renal tubuli with reduction of the intraglomerular pressure.]

Hypertension and nephrology

FEBRUARY 28, 2024

[Novelties and guidelines in cardiology, which can affect patients with chronic kidney failure]

SCHNEIDER Károly

[In cardiological guidelines, many strategic drugs (ACE-inhibitor/ARB, ARNi, beta-blocker, MRA, SGLT2-inhibitor) have made their way into recommendations with 1A level evidence for the prevention and treatment of cardiovascular diseases, depending on the type and severity of cardiovascular involvement and the co-incidence of other various comorbidities in heart conditions. In this summary we are going to elaborate on the fundamental
characteristics of classes of medications with different mechanism of actions,
cardiological evidences for their applications, their effects on patients with chronic renal diseases –, including those with end-stage renal diseases-, focusing mostly on their common cardio- and renoprotective attributes and the cardiological guidelines and the recommendations for patients with chronic renal failure, without attempting to be comprehensive.]

Clinical Neuroscience

JANUARY 30, 2024

Comparison of pre-mortem 2D-3D ultrasound examination to post-mortem micro-CT of carotid arteries – first experiences

SZEGEDI István , SZABÓ András Dániel , EMRI Miklós , BÉRESOVA Mónika , NAGY Mariann , MOLNÁR Sarolta , NAGY Attila , BERÉNYI Ervin , OLÁH László , CSIBA László

A prerequisite for the treatment of carotid atherosclerosis is the accurate measurement of the stenosis, that is most commonly evaluated by duplex ultrasonography. In this study, we aimed to verify the reliability of 2D and 3D ultrasonography, comparing the data to results of post-mortem micro-CT examination. Neurological patients with any life-threatening, presumably fatal neurological disease were enrolled.

Clinical Neuroscience

JANUARY 30, 2024

Factors affecting long-term prognosis in adult patients with psychogenic non-epileptic seizures

MELIHA TURKSEVER, BABURHAN GULDIKEN, HULYA OZKAN, MERVE Melodi CAKAR

Among epileptic patients who are monitored using the video-electroencephalography monitoring (VEM) technique, in some patients a psychogenic non-epileptic seizure (PNES) can be identified as a definitive diagnosis. The longterm prognosis of these patients is not well known. In this study, we aimed to determine the factors that affect the prognosis of PNES. Forty-one PNES patients diagnosed using VEM between 2012 and 2022